Clinical

Dataset Information

0

Adherence and patients’ experiences with capecitabine.


ABSTRACT: Interventions: The use of capecitabine in daily practice will be monitored for 5 cycles. Every cycle takes three weeks. Primary outcome(s): Adherence rate: A patient is adherent with the intake of 85% or more of the prescribed medication. Study Design: N/A: single arm study, N/A , unknown, Parallel

DISEASE(S): Colorectal Cancer, Gastric Cancer And Breast Cancer

PROVIDER: 16613 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2021-09-09 | PXD021593 | Pride
2007-04-27 | GSE7620 | GEO
2013-06-27 | E-GEOD-47870 | biostudies-arrayexpress
| 106782 | ecrin-mdr-crc
2005-07-18 | GSE2537 | GEO
2024-01-26 | PXD043220 | Pride
| 2159311 | ecrin-mdr-crc
2021-10-30 | GSE182426 | GEO
2008-06-12 | E-GEOD-2537 | biostudies-arrayexpress
2020-12-08 | GSE161839 | GEO